To overcome this challenge, it has been demonstrated that suppressing PSD-95 binding to NMDAR acutely post-stroke can restrict excitotoxicity without markedly influencing NMDA activity10, such effects, however have not been demonstrated over longer time frames. The gene discussed is DLG4; the disease is stroke disorder.